BIOMAT Database Logo BIOMAT Database Logo

Effect of dialysis modality and membrane transport characteristics on dialysate protein losses of patients on peritoneal dialysis. 1997

P Kathuria, and H L Moore, and R Khanna, and Z J Twardowski, and S Goel, and K D Nolph
Department of Internal Medicine, University of Missouri, Columbia 65212, USA.

OBJECTIVE To determine if peritoneal dialysis modality has an impact on protein losses in dialysate. METHODS Retrospective, cross-sectional study. METHODS 190 patients who had selected peritoneal dialysis were classified into one of four transport categories (high, high-average, low-average, or low) based on standard peritoneal equilibration test results. Patients were then assigned to continuous ambulatory peritoneal dialysis (CAPD) or nightly intermittent peritoneal dialysis (NIPD) based on membrane transport characteristics and individual preferences. RESULTS Patients with similar membrane transport characteristics had essentially no differences in dialysate protein and albumin losses whether treated with CAPD or NIPD. CONCLUSIONS Although high transporters may be better managed with short-dwell therapies such as nocturnal intermittent peritoneal dialysis or daily ambulatory peritoneal dialysis, consistent marked decreases in protein losses cannot be cited as a benefit of NIPD over CAPD.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010530 Peritoneal Dialysis Dialysis fluid being introduced into and removed from the peritoneal cavity as either a continuous or an intermittent procedure. Dialyses, Peritoneal,Dialysis, Peritoneal,Peritoneal Dialyses
D010531 Peritoneal Dialysis, Continuous Ambulatory Portable peritoneal dialysis using the continuous (24 hours a day, 7 days a week) presence of peritoneal dialysis solution in the peritoneal cavity except for periods of drainage and instillation of fresh solution. CAPD,Continuous Ambulatory Peritoneal Dialysis
D010537 Peritoneum A membrane of squamous EPITHELIAL CELLS, the mesothelial cells, covered by apical MICROVILLI that allow rapid absorption of fluid and particles in the PERITONEAL CAVITY. The peritoneum is divided into parietal and visceral components. The parietal peritoneum covers the inside of the ABDOMINAL WALL. The visceral peritoneum covers the intraperitoneal organs. The double-layered peritoneum forms the MESENTERY that suspends these organs from the abdominal wall. Parietal Peritoneum,Peritoneum, Parietal,Peritoneum, Visceral,Visceral Peritoneum,Parametrium,Parametriums
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D001824 Body Constitution The physical characteristics of the body, including the mode of performance of functions, the activity of metabolic processes, the manner and degree of reactions to stimuli, and power of resistance to the attack of pathogenic organisms. Body Constitutions,Constitution, Body,Constitutions, Body
D001830 Body Surface Area The two dimensional measure of the outer layer of the body. Area, Body Surface,Areas, Body Surface,Body Surface Areas,Surface Area, Body,Surface Areas, Body
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001693 Biological Transport, Active The movement of materials across cell membranes and epithelial layers against an electrochemical gradient, requiring the expenditure of metabolic energy. Active Transport,Uphill Transport,Active Biological Transport,Biologic Transport, Active,Transport, Active Biological,Active Biologic Transport,Transport, Active,Transport, Active Biologic,Transport, Uphill

Related Publications

P Kathuria, and H L Moore, and R Khanna, and Z J Twardowski, and S Goel, and K D Nolph
Relationship between dialysate oxidized protein and peritoneal membrane transport properties in patients on peritoneal dialysis.
October 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
P Kathuria, and H L Moore, and R Khanna, and Z J Twardowski, and S Goel, and K D Nolph
Peritoneal Protein Losses Depend on More Than Just Peritoneal Dialysis Modality and Peritoneal Membrane Transporter Status.
April 2018, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy,
P Kathuria, and H L Moore, and R Khanna, and Z J Twardowski, and S Goel, and K D Nolph
Dietary protein requirements and dialysate protein losses in chronic peritoneal dialysis patients.
January 2007, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis,
P Kathuria, and H L Moore, and R Khanna, and Z J Twardowski, and S Goel, and K D Nolph
The relationship between dialysate protein loss and membrane transport status in peritoneal dialysis patients.
January 2001, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis,
P Kathuria, and H L Moore, and R Khanna, and Z J Twardowski, and S Goel, and K D Nolph
Peritoneal transport characteristics with glycerol-based dialysate in peritoneal dialysis.
January 2000, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis,
P Kathuria, and H L Moore, and R Khanna, and Z J Twardowski, and S Goel, and K D Nolph
Effect of peritoneal dialysis prescription and peritoneal membrane transport characteristics on nutritional status.
January 1995, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis,
P Kathuria, and H L Moore, and R Khanna, and Z J Twardowski, and S Goel, and K D Nolph
Dialysate copeptin and peritoneal transport in incident peritoneal dialysis patients.
September 2019, International urology and nephrology,
P Kathuria, and H L Moore, and R Khanna, and Z J Twardowski, and S Goel, and K D Nolph
Urinary and dialysate losses of vitamin D-binding protein in children on chronic peritoneal dialysis.
April 2012, Pediatric nephrology (Berlin, Germany),
P Kathuria, and H L Moore, and R Khanna, and Z J Twardowski, and S Goel, and K D Nolph
Peritoneal membrane characteristics in patients on peritoneal dialysis.
January 2011, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia,
P Kathuria, and H L Moore, and R Khanna, and Z J Twardowski, and S Goel, and K D Nolph
Peritoneal Phosphate Clearance: The Effect of Peritoneal Dialysis Modality and Peritoneal Transport Status.
January 2017, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis,
Copied contents to your clipboard!